Clinical Manifestations and Diagnosis of Fibromuscular Dysplasia

Clinical Presentation

The American Heart Association notes that FMD is a nonatherosclerotic, noninflammatory vascular disease that most commonly presents as hypertension in young to middle-aged women, though it can affect both genders at any age and involves multiple arterial territories throughout the body 1, 2
Hypertension is the hallmark presentation, particularly in patients aged ≤35 years with new-onset hypertension, according to the American College of Cardiology 3
Severe hypotension or azotemia provoked by ACE inhibitors or ARBs suggests hemodynamically significant renal artery stenosis, as stated by the American Heart Association 3
FMD characteristically involves the middle and distal two-thirds of the main renal artery and may extend into branches, unlike atherosclerotic disease which affects the ostial and proximal segments, as noted by the American College of Cardiology 3
Medial fibroplasia accounts for 80-85% of renal FMD cases and typically affects both renal arteries in women aged 25-50 years, according to the American Heart Association 3
Stroke or transient ischemic attack (TIA) from reduced blood flow or thromboembolism can occur in patients with FMD, as stated by the American Stroke Association 1, 2
Carotid or vertebral artery dissection, which can occur spontaneously, is a recognized complication of FMD, according to the American Heart Association 1, 2
Horner syndrome from carotid involvement can occur in patients with FMD, as noted by the American Academy of Neurology 1, 2
Cranial nerve palsies can occur in patients with FMD, according to the American Academy of Neurology 1, 2
Subarachnoid hemorrhage from aneurysmal rupture is a potential complication of FMD, as stated by the American Heart Association 1, 2

Diagnostic Approach

The American College of Cardiology recommends duplex ultrasonography as the initial screening test for renal artery FMD, while CT angiography or MR angiography from head to pelvis should be performed at diagnosis to identify the systemic nature of the disease 3, 4, 5
Computed tomographic angiography (CTA) is recommended in patients with normal renal function, according to the American College of Radiology 3, 4
Magnetic resonance angiography (MRA) is an alternative screening modality, as stated by the American College of Radiology 3, 4
Contrast-enhanced CTA, MRA, or catheter angiography are all useful for diagnosing cervical artery dissection, according to the American Heart Association 1, 2
Catheter-based contrast angiography should be performed when clinical suspicion is high and noninvasive tests are inconclusive, as recommended by the American College of Cardiology 4, 5
The "string of beads" appearance is pathognomonic for medial fibroplasia, where the diameter of the beading is larger than the normal arterial diameter, as noted by the American College of Cardiology 3
Focal stenosis can occur with intimal fibroplasia, appearing as concentric or tubular narrowing similar to atherosclerotic disease, according to the American Heart Association 1, 2
Weblike lesions may obstruct flow, as stated by the American Heart Association 1, 2
Aneurysmal dilation can be present, according to the American Heart Association 1, 2

Surveillance and Monitoring

Annual noninvasive imaging of the carotid arteries is reasonable initially to detect changes in disease extent or severity, as recommended by the American Heart Association 1, 2, 4, 5
Imaging frequency may be reduced once stability has been confirmed over time, according to the American Heart Association 1, 2, 4, 5

Cerebrovascular Complications and Diagnostic Recommendations in Fibromuscular Dysplasia

Cerebrovascular Complications

Carotid or vertebral artery dissection is reported in approximately 12 % of individuals with fibromuscular dysplasia, representing a recognized vascular complication. 6
Horner syndrome—characterized by ptosis, miosis, and anhidrosis—may arise from carotid artery involvement in fibromuscular dysplasia. 7
Cranial nerve palsies can occur secondary to carotid‑segment fibromuscular dysplasia. 7
Subarachnoid hemorrhage may result from rupture of aneurysms associated with fibromuscular dysplasia. 6
Unilateral head or neck pain is a typical presenting symptom of cervical artery dissection in fibromuscular dysplasia. 6
Vertebral artery dissection may manifest with headache, neck pain, vertigo, nausea, visual disturbances, or syncope. 6

Pathological Features

Gross arterial pathology in fibromuscular dysplasia includes elongation, kinking, coiling, spontaneous dissection, and aneurysmal degeneration. 7

Renal Diagnostic Recommendations

Renal artery Doppler ultrasonography with bilateral assessment of the renal arterial resistive index is recommended for patients with suspected renovascular hypertension. 8

Laboratory Assessment

Markedly elevated renin levels increase suspicion for renovascular hypertension in fibromuscular dysplasia, although the test lacks high sensitivity. 8
Evaluation of dietary sodium intake—using 24‑hour urinary sodium or a sodium‑to‑creatinine ratio in a morning urine sample—is important for accurate interpretation of renin measurements. 8

Guidelines for Diagnosis and Management of Carotid Fibromuscular Dysplasia

Diagnostic Approach

In women < 50 years presenting with unexplained transient ischemic attacks and a neck bruit, the first‑line test should be contrast‑enhanced CTA or MRA to confirm carotid FMD and to look for the characteristic “string‑of‑beads” appearance or focal stenosis (American Heart Association, Class I) 9.
CTA, MRA, and catheter‑based contrast angiography are all Class I useful modalities for diagnosing carotid FMD (American Heart Association) 9.
Duplex ultrasonography can detect flow abnormalities but is less reliable for morphologic diagnosis compared with cross‑sectional imaging (American Heart Association) 9.

Key Imaging Findings

The “string‑of‑beads” pattern is pathognomonic for medial fibroplasia, the most common FMD subtype (≈ 80‑85 % of cases) (American Heart Association) 9.
Focal, concentric, or tubular stenosis suggests intimal fibroplasia and can mimic atherosclerotic narrowing (American Heart Association) 9.
Additional arterial abnormalities to seek include elongation, kinking, coiling, weblike lesions, and aneurysmal dilation (American Heart Association) 9.
Carotid FMD typically involves the middle and distal segments of the internal carotid artery bilaterally, whereas atherosclerosis preferentially affects proximal segments (American Heart Association) 9.

Associated Complications to Screen

Approximately 15 % of patients with carotid FMD develop an arterial dissection, which may occur spontaneously (American Heart Association) 9.
Screen for cranial nerve IX–XII palsies and for subarachnoid hemorrhage secondary to aneurysmal rupture (American Heart Association) 9.

Management Strategy

Medical Therapy

Antiplatelet therapy is the accepted standard for all patients with carotid FMD, including those who are asymptomatic (American Heart Association) [9][10].
In patients with an associated dissection and ischemic symptoms, a 3‑6 month course of antithrombotic treatment—either anticoagulation (heparin, LMWH, or warfarin) or antiplatelet agents (aspirin, clopidogrel, or extended‑release dipyridamole + aspirin)—is reasonable (Class IIa) (American Heart Association) 9.
If ischemic symptoms persist despite antithrombotic therapy after an acute dissection, carotid angioplasty and stenting may be considered (Class IIb) (American Heart Association) 9.

Revascularization

For symptomatic carotid FMD causing recurrent ischemic events, initiate antiplatelet therapy immediately and consider percutaneous angioplasty with or without stenting (American Heart Association; American Stroke Association) [9][10].
Both surgical revascularization and endovascular approaches have been reported successful in relieving ischemic symptoms (American Heart Association; American Stroke Association) [9][10].
Percutaneous angioplasty (± stent) is increasingly advocated based on case series, although no randomized trials compare it with surgical repair (American Heart Association; American Stroke Association) [9][10].

Surveillance Protocol

Sequential non‑invasive imaging (CTA or MRA) of the carotid arteries is recommended even for asymptomatic patients to monitor disease extent and detect progression, new dissection, or aneurysmal change (American Heart Association; American Stroke Association) [9][10].

Clinical Pitfalls

Do not assume atherosclerotic disease in young women with carotid stenosis; bilateral involvement, mid‑to‑distal location, and the beading pattern are distinguishing features of FMD (American Heart Association) 9.
Maintain a high index of suspicion for dissection in ≈ 15 % of carotid FMD patients—new neck pain, Horner syndrome, or worsening neurologic deficits should prompt urgent evaluation (American Heart Association) 9.
Symptoms arise from either reduced cerebral perfusion or thromboembolism originating from the irregular arterial surface (American Heart Association; American Stroke Association) [9][10].

Stroke Risk and Management in Fibromuscular Dysplasia

Epidemiology of Cerebrovascular Events in FMD

Approximately 9.8 % of individuals with fibromuscular dysplasia experience an ischemic stroke, 13.4 % have a transient ischemic attack, and 12 % develop cervical artery dissection, a major mechanism of stroke in this population【11】【12】.
Women are disproportionately affected; the condition occurs most frequently in middle‑aged females, although it can be present at any age and in both sexes【11】.

Pathophysiologic Mechanisms Linking FMD to Stroke

Thromboembolic nidus: Fibrous webs and irregular arterial surfaces created by FMD serve as sites for platelet deposition, predisposing to embolic stroke or TIA【11】【12】.
Reduced cerebral perfusion: Stenosis, occlusion, and the characteristic “string‑of‑beads” appearance from medial fibroplasia diminish blood flow to the brain, increasing ischemic risk【11】【12】.
Aneurysmal rupture: Although less common than ischemic events, aneurysms associated with FMD can rupture and cause subarachnoid hemorrhage【11】.
Pro‑thrombotic arterial wall changes: The structural alterations in the arterial media and intima generate a pro‑thrombotic environment, further elevating stroke risk【11】【12】.
Fibrous webs as flow obstacles: Multiple fibrous webs obstruct arterial flow and act as focal points for platelet aggregation【12】.

Guideline Recommendations for Patients with FMD and Cerebrovascular Events

The 2021 American Heart Association/American Stroke Association (AHA/ASA) Stroke Prevention Guidelines identify fibromuscular dysplasia as an independent stroke risk factor and issue Class I (strong) recommendations for:
- Antiplatelet therapy,
- Blood‑pressure optimization, and
- Lifestyle modification (e.g., smoking cessation, regular exercise) in FMD patients who have experienced a stroke or TIA【11】【12】.

All facts are derived from peer‑reviewed sources cited above.